Replies to post #1986 on Enanta Pharmaceuticals Inc (ENTA)

[vinmantoo]

ABBV 2Q21 Mavyret sales=$441M, +6% QoQ:........

New-patient starts are increasing but are not (yet) back to pre-pandemic levels.

Great as it gives me plenty of time to add more before ENTA rebounds.